Share of the population living with HIV in Angola
Angola: Share of the population living with HIV was 1.6% in 2024. ▲ Rising
Share of the population living with HIV in Angola, 1990–2024
Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in %.
Analysis
In 2024, share of the population living with hiv in Angola stood at 1.6%.
Compared with earlier readings it is down 2.2% on the previous year and down 12.4% over ten years.
Over the whole period, share of the population living with hiv in Angola peaked at 1.8% in 2015 and was at its lowest, 0.5%, in 1990.
Angola ranks 24th of 150 countries on this measure, in the top quarter.
The long-run direction has been consistently rising across the 35 years of available data.
Share of the population living with HIV in Angola, year by year
| Year | % | Change |
|---|---|---|
| 1990 | 0.5% | — |
| 1991 | 0.6% | +17.4% |
| 1992 | 0.7% | +16.4% |
| 1993 | 0.8% | +13.9% |
| 1994 | 0.9% | +12.1% |
| 1995 | 1.0% | +10.6% |
| 1996 | 1.1% | +8.9% |
| 1997 | 1.2% | +7.5% |
| 1998 | 1.2% | +6.3% |
| 1999 | 1.3% | +5.6% |
| 2000 | 1.4% | +4.7% |
| 2001 | 1.4% | +3.9% |
| 2002 | 1.5% | +3.5% |
| 2003 | 1.5% | +3.1% |
| 2004 | 1.6% | +2.5% |
| 2005 | 1.6% | +2.3% |
| 2006 | 1.6% | +1.8% |
| 2007 | 1.7% | +1.8% |
| 2008 | 1.7% | +1.9% |
| 2009 | 1.7% | +1.6% |
| 2010 | 1.7% | +1.1% |
| 2011 | 1.8% | +0.9% |
| 2012 | 1.8% | +0.7% |
| 2013 | 1.8% | +0.4% |
| 2014 | 1.8% | +0.5% |
| 2015 | 1.8% | +0.1% |
| 2016 | 1.8% | -0.4% |
| 2017 | 1.8% | -0.9% |
| 2018 | 1.7% | -1.1% |
| 2019 | 1.7% | -1.4% |
| 2020 | 1.7% | -1.5% |
| 2021 | 1.7% | -1.7% |
| 2022 | 1.6% | -1.9% |
| 2023 | 1.6% | -2.1% |
| 2024 | 1.6% | -2.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 0.9% | 0.5% | 1.3% | 10 |
| 2000s | 1.6% | 1.4% | 1.7% | 10 |
| 2010s | 1.8% | 1.7% | 1.8% | 10 |
| 2020s | 1.6% | 1.6% | 1.7% | 5 |
Countries ranked near Angola
More health data for Angola
- Un projection of annual infant deaths, annual growth rate -1.27 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.05 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 740.2 deaths per 1,000 people (2090)
- Number of infants who die before age 1 31,754 deaths (2100)
- Total tetanus - number of reported cases, gaps filled 992 (2025)
- Total tetanus - number of reported cases, per capita 0 units per person (2025)
- Diphtheria - number of reported cases, gaps filled 0 (2025)
- Diphtheria - number of reported cases, per capita 0 units per person (2025)
- Measles - number of reported cases, gaps filled 2,043 (2025)
- Measles - number of reported cases, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is share of the population living with hiv in Angola?
- Share of the population living with hiv in Angola was 1.6% in 2024, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
- What is the highest share of the population living with hiv recorded in Angola?
- The highest recorded value was 1.8% in 2015.
- What is the lowest share of the population living with hiv recorded in Angola?
- The lowest recorded value was 0.5% in 1990.
- How does Angola rank for share of the population living with hiv?
- Angola ranks 24th out of 150 countries with data for 2024.
- Is share of the population living with hiv rising or falling in Angola?
- Over the last ten years it is down 12.4%. The long-run trend across the full record is rising.
- Where does this Angola data come from?
- The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of Share of the population living with HIV. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of people aged 15-49 who test positive for HIV at a given time. This is the central estimate.